The FcγR/IgG Interaction as Target for the Treatment of Autoimmune Diseases. (Q53163397)

12 May 2018

title

The FcγR/IgG Interaction as Target for the Treatment of Autoimmune Diseases. (English)

1 reference

12 May 2018

author name string

Peter Sondermann

series ordinal

1

1 reference

12 May 2018

publication date

2 April 2016

1 reference

12 May 2018

Journal of Clinical Immunology

published in

1 reference

12 May 2018

volume

36 Suppl 1

1 reference

12 May 2018

page(s)

95-99

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1007/s10875-016-0272-7

exact match

0 references

cites work

Fcgamma receptors as regulators of immune responses

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Glycosylation as a strategy to improve antibody-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Fc receptors and their interaction with complement in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Release of soluble Fc gamma RII/CD32 molecules by human Langerhans cells: a subtle balance between shedding and secretion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Immunoglobulin-binding factor present on and produced by thymus-processed lymphocytes (T cells)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Recombinant soluble receptors for the Fc gamma portion inhibit antibody production in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Recombinant soluble Fc gamma receptors: production, purification and biological activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Soluble CD16 in the treatment of murine lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Ligands and biological activities of soluble Fc gamma receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Human Fcgamma receptor IIb expressed in Escherichia coli reveals IgG binding capability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Characterization and crystallization of soluble human Fc gamma receptor II (CD32) isoforms produced in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

The Human Low Affinity Fcγ Receptors IIa, IIb, and III Bind IgG with Fast Kinetics and Distinct Thermodynamic Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Crystal structure of the soluble form of the human fcgamma-receptor IIb: a new member of the immunoglobulin superfamily at 1.7 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

FcRn: the neonatal Fc receptor comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Multivalent immune complexes divert FcRn to lysosomes by exclusion from recycling sorting tubules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

X-ray crystallographic studies of IgG-Fc gamma receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Suppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor complex and Fcγ receptor IIb inhibitory receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

Characterization of SM201, an anti-hFcγRIIB antibody not interfering with ligand binding that mediates immune complex dependent inhibition of B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-016-0272-7

IgG subclasses and allotypes: from structure to effector functions

21 January 2018

1 reference

12 December 2020

SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis

1 reference

12 December 2020

Amelioration of collagen-induced arthritis by human recombinant soluble FcgammaRIIb

1 reference

12 December 2020

FcγRIIb controls bone marrow plasma cell persistence and apoptosis

1 reference

12 December 2020

A soluble form of the human Fc receptor Fc gamma RIIA: cloning, transcript analysis and detection.

1 reference

12 December 2020

Human monocyte cell line (U937) releases suppressive IgG-binding factor(s)

1 reference

12 December 2020

Roles of Fc receptors in autoimmunity

1 reference

12 December 2020

Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes. Induction of cleavage of L-selectin via CD16

1 reference

12 December 2020

10.1007/S10875-016-0272-7

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

27039179

1 reference

12 May 2018